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SECTION A 
Can Calvary Survive? 
CRITICAL INCIDENT 
Since the beginning of March 1997, the production situation at 
Calvary had become critical. Suddenly, they were f aced with an 
apparently insurmountable task of meeting the increased 
requirements for the domestic market, over the already increased 
demand for production time placed on them by the export orders and 
the critical shortage of stocks in government hospitals. 
The increased demand for the domestic sector was attributed to the 
fact that plans implemented by the management of Danco 
Pharmaceutical, were just coming on-stream. Since the acquisition of 
Calvary Industries towards the end of 1996, the business plan for the 
coming years had spelt for the up-scaling of domestic sales from 
RM 2 .9 million in 1996 to about RM 13.75 million by the year 2 000. 
The immediate requirements of Danco Pharmaceutical called for 
production to meet a sales budget of R M  5.5 million in 1997, if the 
plan of R M  13.75 million was to be achieved. 
The inventory level as at January 15 1997 was valued at RM 285, 000 
and the situation was so bad that up to R M  75,000 worth of sales were 
in back-order! It was evident that something had to be done fast 
enough to achieve desirable inventory levels. Furthermore, Danco 
Pharmaceutical had embarked on an image building course and 
quality was being emphasised, from both the perspective of the 
products it marketed and the services it provided. 
This meant that customers' orders had to be fulfilled within the 
shortest possible response time, factors which Danco Pharmaceutical 
considered provided them the competitive edge in securing the 
business from its competitors. 
COMPANY BACKGROUND 
The company had its origin in 1972 when a group of people got 
together and established the business. The principal people were a 
sales representative, Mr. Stephen Lim and a production assistant, 
Mr. Tan Tock Seng, both of whom were previously with a company 
called United Pharmaceutical, a British-owned company which went 
bankrupt that very year. Together with a UK qualified pharmacist, 
Mr. Chee Seng Chan, they set up the company Calvary 
Pharmaceutical Chemist, a name derived from the town of Calvary, a 
suburb of London, where Mr. Chee lived while he was in the United 
Kingdom. 
At start-up, Calvary was housed in a 1,500 square feet rented shoplot 
in Butterworth and was involved in the manufacture of a limited 
range of liquid preparations only. A few years later, they expanded 
their business downstream by opening their first pharmacy under the 
same name, which was located where KOMT AR now stands. 
However, the pharmacy did not do well and was subsequently closed 
down. It was soon after this in 1979, that one of the partners, 
Mr. Chee decided he had had enough with the business and gave up 
his partnership. 
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The remaining two original partners subsequently approached the 
Kew family, led by Mr. Kew Teng Choo, a qualified pharmacist, to 
invest in Calvary. In 1979, with Mr. Kew Teng Choo on board as the 
General Manager, Mr. Stephen Lim as the Marketing Manager and 
Mr. Tan Tock Seng as the Production Manager, the company name 
was changed to Calvary Industries, a name that existed to the present 
day. At the same time, they initiated a production expansion 
programme, going into the manufacture of solid oral preparations, 
namely tablets and capsules. 
Annual sales in the early seventies were between 70,000 and 80,000 
dollars (the Malaysian currency unit then), and by the early eighties, 
had crossed the one million mark. 
In 1981, Calvary was relocated to its new premises, a 6,000 square 
foot factory lot located in the Prai area, with expansion to its 
production facilities. It sales were mainly to clinics and pharmacies in 
the private sector of the Northern Region of the country, from Perlis 
to Perak, but not beyond the town of Ipoh. 
It was in 1985-1986, with increased expertise in production, that 
Calvary was successful in securing its first Ministry of Health, 
Government of Malaysia tenders for the supply of pharmaceuticals. 
The total contract for the supply of such products as the antibiotics 
Ampicillin capsules and Erythromycin tablets as well as the antiseptic 
Chlorhexidine solution, was valued at four million dollars 
(approximately 2 million dollars a year, as the contract awarded was 
for a supply over a two year period). 
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Disaster struck the following year when fire razed through the plant, 
causing damages of approximately one million dollars in production 
facilities and inventories. The latter included both raw materials and 
finished goods. As a result of this fire, Calvary was shut down for 
about six months and although the plant was fully insured, insurance 
recovery claims amounted to approximately eight hundred thousand 
dollars, on account that the plant was under-insured. 
After the fire, the factory was relocated to its new premises, where it 
is currently sited. 
Calvary was principally involved in the manufacture of its own range 
of pharmaceuticals. Production output was to meet both the 
domestic as well as the export markets in which its products were 
present. On the domestic sector, Calvary produced to sell to private 
clinics, pharmacies and private hospitals, which it classified as private 
sector sales. The other segment on the domestic front was sales to 
government hospitals, through the tender system. 
In addition, to fully utilize its capacity, it undertook contract 
manufacture for third parties. Contract manufacturing was 
undertaken mainly for the business friends and acquaintances and of 
the Kew family, particularly Mr. Kew Teng Choo. 
As for the product range Calvary produced, it began with the 
production of galenical preparations such as syrups and mixtures. 
With the expansion programmes undertaken, the company 
introduced preparations in the form of ointments and creams as well 
as tablets and capsules. In addition, it introduced upgraded 
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packaging types to further improve the product presentations. This 
occurred following capital investments in machinery such as the 
blister-packaging and strip-packaging machines, sachet filling and 
packaging and semi-automatic and automatic capsule filling 
machines. 
A relevant point to note was that most of the upgrading programmes 
were implemented towards the end of the eighties and the early 
nineties. Central to this decision were the combined factors of 
regulatory compliance as well as the increasing export sales 
performance. To ensure competitiveness in the international markets 
it served, Calvary had to significantly improve its product 
presentation. The local market was, on the other hand, less sensitive 
to the aesthetics of the product but more sensitive to price offerings. 
Competition on the domestic front faced by the company were 
mainly on two fronts. On one front was that presented by the well 
established multinational companies (MNCs) which had operations in 
Malaysia either as agencies or subsidiaries. These MNCs utilised 
powerful marketing programmes set by their respective corporate 
headquarters. Implementation of these marketing programmes were 
supported by heavy advertising and promotions (A&P) budgets. 
Product pricing was generally up-market and the reason cited for this 
was the high investments in research and development (R&D) which 
were to be recovered during the Patent period1. 
Competition on the second front was from the twenty five odd local 
manufacturers in Malaysia. These companies were characterised by 
1 The Patent period was a time-frame during which the patentee was legally accorded 
protection against patent infringements and copies. 
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the fact that they were manufacturers of off-patented products, 
offering their products to the market generally at a fraction of the 
costs of the original branded products. The price differentials were in 
the range of 10% to 30% of the original branded products. The 
principal reason why such local companies could do so was due to 
the fact that once a particular substance goes off-patent, the raw 
materials could be freely manufactured by numerous suppliers. In 
this manner, market forces of supply and demand dictate prices, 
translating into substantially reduced pricing of the finished products. 
For the period from 1986 to 1993, sales had plateaued at the RM 2 
million mark. To overcome the stagnation of sales, it was realized 
that there was a need for active marketing of Calvary products, given 
the very intense competition from the local manufacturers. Mr. Kew 
embarked on establishing a Marketing Department in 1994, which 
was based in Kuala Lumpur. The Sales and Marketing operations 
consisted of a Marketing Manager and a team of six sales 
representatives. 
After a short foray of 15 months from August 1994 to October 1995, 
the sales and marketing operations was found to have had limited 
success, with untold losses amounting from ill-conceived marketing 
plans and substantial inventory build-up. 
Sales for 1995 was at the RM 2.2 million level, following which a 
decision was then taken to contract one of the major established local 
distributors of pharmaceuticals in the country, to perform the 
Marketing and Distribution function. 
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To this effect, an agreement was finalised with Antah Pharma Sdn. 
Bhd., a subsidiary of public listed Antah Holdings Berhad, to begin 
operations in late 1995. 
Antah Pharma increased private sector (government sector tender 
sales were handled by Calvary directly) sales by approximately 30% 
from the previous year's sales level. Nevertheless, the 1996 turnover 
of RM 2.6 million was far below those of Calvary's major competitors 
in the Malaysian market-place. 
One factor which partly contributed to the sales situation in 1996 was 
the frequent stock out position for most of the major selling products 
of Calvary, brought about by the inadequate sales forecasting 
techniques employed by Antah Pharma. The forecast system used 
was one based on the average 6-months sales history, on which re­
order decisions were made for stocks replenishment, such that not 
more than 3 months inventory was held at anytime. 
Towards end 1996, Calvary entered into negotiations with Danco 
Resources Corporation Sdn. Bhd., for the sale of the company and by 
end February 1997, marketing operations were transferred to Danco 
Pharmaceutical Sdn. Bhd., the strategic business unit of Danco 
Resources Corporation responsible for marketing within the Group. 
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Strategic Planning 
To all intents and purposes, Calvary did not have any strategic plans 
developed for its long-term survival. O perations were run along 
traditional lines, without a clear strategic vision, mission statements 
and goals. Turnover was registered on the basis of whatever sales 
that came its way. 
Operational plans, however, were well established for optimal 
functioning of the production process and production scheduling was 
performed on a weekly basis, allowing for re-scheduling should there 
be an urgent requirement to do so. In this respect, Calvary had the 
advantage of production flexibility. 
With Danco Pharmaceutical on board, the Holding Company, Danco 
Resources drew up the strategic plans and sales objectives to enable 
the vision to be achieved. The Vision, mission and goals were 
espoused as follows: 
Vision Statement 
To be a fully integrated Malaysian Healthcare company in the promotion, 
prevention, curing and rehabilitation of diseases in mankind. 
Mission Statement 
To achieve the leading position in the Malaysian Pharmaceutical Industry 
by the year 2000 through enhanced customer service and customer 
satisfaction. 
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The Goals 
• To achieve a total sales of RM 5.5 million in 1997 and RM 8.25 million by 
1998. 
• To have integrated and coordinated operations to achieve the targetted 
sales goals and to meet enhanced customer satisfaction. 
• To be listed on the Second Board of the Kuala Lumpur Stock 
Exchange(KLSE) by 1999. 
Factory Location, Land Space and Floor Space 
The factory had been located at the present site since 1987, after fire 
gutted the 6,000 square feet facility at 10, Solok Perusahaan 4, 
Kawasan MIEL, Prai Industrial Estate, Prai. The original land area at 
Lot 998 was 19,000 square feet with a built-up area, initially of 12,450 
square feet (refer to Table Al of Appendix A). As production 
demand increased following sales development in both domestic and 
export markets, an expansion was undertaken in 1994, by way of the 
acquisition of the neighbouring plot of land of almost similar size 
which provided the needed floor space to cope with the capacity 
requirements. 
In 1997, an additional production space of 2,000 square feet was 
obtained by way of utilization of the first floor space above the liquid 
packing area, for the creation of high volume liquid manufacturing. 
Despite the significant doubling of floor space capacity between 1987 
and 1994, it was realized three years later in early 1997, that the 
existing available area was insufficient for continued operations to 
cope with expected volume development into the next millennium. 
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However, further expansion at the existing location was not going to 
be possible as all 38,412 square feet of land space had been fully 
utilized. There were no adjoining plots of land available for purchase. 
Land space in the Prai Industrial Area had a high density of usage, 
consequent to which it had become scarce. The only possibility 
would be on a "willing buyer - willing seller" basis. Given this 
scenario, land prices were expected to be astronomical. Current 
going prices were in the range of RM 700,000 per acre, with an 
increasing trend almost on a monthly basis. 
Human Resources 
The general development of human resources at the company was as 
shown in Table A3 of Appendix A. Staff strength growth was 
significant after 1989. With a staff strength of 30 in 1987 and 36 in 
1989, representing a growth of 20%, another 16 people (44%) joined 
the organization in 1992. For the following four years, the numbers 
remained fairly constant, until June 1997, when a 35% increase in staff 
numbers to 84 was observed (see Table 1, overleaf). 
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Table 1: Summary data of Human Resource development 
Year : Number 
i of Staff 
Number of staff in each Functional Area 
Prod QC 1M Admin Main. S&M 
Key 
Staff 
·········
1"
987·······"]
""·······
""3
·
0
··········· 
18 4 3 2 1 2 3 
·········1"989 ········1···········3·6··········· ······"1"9········ ········4········· ········5········· ···········5 ·········· ......... 1" ......... ......... 2" ......... ·········5········· 
·········1"990"········1···········5·2··········· ·······28········ ......... 7" ........ ......... 7" ........ ···········7·········· ......... 1" ......... ·········2·········· ·········6········· 
·········1"995·········] ··········§j"·········· ·······25······· ······ .. 9········· ········5········· ·········12········· ........ "3 .......... ........ "3 .......... ·······10······· 
·········1"997········1···········6·2""········· ·······32 ······· ......... 7" ........ ....... "4"" ....... ·········14········· ·········3·········· ·········2·········· ·······11"······· 
···w�f·j���···1···········8·4··········· ·······51""······ ········9········· ........ (, ......... ·········13········· ........ "3 .......... ......... 2" ......... ·······11""······ 
1997 : 
Source: Calvary Personnel Records 
Legend: 
Prod = Production QC = Quality Control 
IM = Inventory Management Main = Maintenance 
Admin = Administration 
S&M = Sales & Marketing 
Most of the growth over the decade from 1987 were in the areas of 
Operations - in Production, Quality Control and Warehousing, 
although administration also saw an increase along with plant 
maintenance. During the intervening years, there were fluctuations 
in staff numbers, and it became more difficult to recruit staff, as most 
potential staff were looking to the more lucrative electronic industries 
for employment. 
In June 1997, a decision was taken to increase staff strength from an 
overall total figure of 62 to 84 people, with the recruitment of 22 
additional staff. Nineteen of them (86%) were recruited mainly for 
production; quality control and inventory management each saw an 
increase of two staff. 
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This change was the result of a response to the increasing sales trend 
from domestic marketing through the marketing unit of Danco 
Pharmaceutical Sdn. Bhd. Furthermore, there was also an increase in 
tender supplies to the Malaysian Ministry of Health and over­
whelming export orders from abroad. 
The management philosophy governing career advancements and 
promotions within Calvary was based on sourcing of managerial 
talents from within the organization (internal promotions) before 
external recruits were considered. In line with this philosophy, 
employees were provided with on-the-job training as well as 
provided opportunities for job enrichment through job rotations. 
This was particularly so during the stable years between 1990 and 
1996, when some employees were assigned to various positions and 
departments within the organization, particularly those in 
Operations. 
Besides the training mode mentioned above, however, there were no 
other formal training provided. A handful of the employees pursued 
additional training, at their own interest with a special company 
provident fund, in areas such as basic management and basic 
computer training. 
Promotions to key staff positions from six in 1990 to eleven in 1997 
was effected from within the organization. This had resulted in the 
organization having a core of long serving, experienced staff in key 
positions, rendering a stable and experienced management group. 
Each key employee had an average of no less than five years service 
with the company. 
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Production Facilities 
The introduction and development of the various production facilities 
can be followed by an examination of Table A4, while the detailed 
listing, in terms of the manufacturing equipment, are as outlined in 
Table AS in Appendix A. Principally, these were for the manufacture 
of the entire range of pharmaceuticals that Calvary offered its 
customers. These include the oral solids such as tablets, capsules and 
granules for reconstitution of suspensions. 
Galenicals include the oral liquids such as syrups and suspensions as 
well as the external preparations including suspensions and lotions, 
ointments, creams, liniments and drops for instillation. 
The introduction of production equipment was done at the various 
stages of development of the business, to accommodate the increase 
in the business turnover as well as to cater to the increased 
sophistication of packaging technologies. The other reason for the 
adding on of equipment was to enhance production efficiencies 
through utilization of higher capacity machines. 
With all the equipment Calvary had as at June 1997, the available 
space was maximally utilised. A study of the plant layout plan in 
Exhibit Al will indicate the critical state Calvary was in should 
further expansion be necessary. 
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When the company began operations in 1972, they were into the 
manufacture of liquid preparations and at that time, basic equipment 
comprised mixing tanks and mixers. In 1980, when the production of 
tablet preparations was ventured into, was there a need to include 
tablet making equipment of mixers, granulators, ovens and tabletting 
machines. This remained the mainstay of solid dosages until semi­
automatic capsuling machines were acquired for the manufacture of 
capsule preparations. A double layered tabletting machine was 
added to manufacture tablets with two different colours, a hallmark 
of some of the tablet preparations on the market then which managed 
to capture significant market shares through a unique presentation. 
The occurrence of a fire at the factory in July 1987 was a setback for 
Calvary, as all equipment were destroyed, except for a few machines 
which staff managed to salvage. This resulted in Calvary not being 
able to undertake any production for about six months. However, 
with the few salvaged machines and while awaiting the delivery of 
new machines following the fire, Calvary was able to resume 
tabletting a limited range of products to keep the product lines in the 
market-place. 
Loss of production facilities were in excess of one million ringgit but 
insurance claim resulted in about nine hundred thousand ringgit 
being recovered. This was because the net worth of the facilities at 
that time were under insured. Nevertheless, from the insurance 
recovery, Calvary made new equipment purchases which have been 
in use till current day. 
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